Elaine Merisko‐Liversidge

Author

Also Known As

E. Merisko-Liversidge, Elaine M. Merisko-Liversidge, Elaine Merisko-Liversidge, Elaine Merisko-liversidge, Elaine Merisko‐Liversidge

Publications

Citations

H-Index

Concepts

All Affiliations

Sterling Research Group University of Kansas Medical Center Alkermes (United States)

About

Elaine Merisko‐Liversidge is an author at Sterling Research Group specializing in medicine, pharmacology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	86
2	Engineering	2	2	83
3	Biomedical Engineering	2	2	83
4	Biochemistry	1	1	10
5	Biomolecular Engineering	1	1	25

Elaine Merisko‐Liversidge

Publications

541

Citations

H-Index

Page 1

	Year	Citations
Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs Elaine Merisko‐Liversidge, Pramod P. Sarpotdar, Joseph G. Bruno, Pharmaceutical Research	1996	231
Nanocrystal Biolabels with Releasable Fluorophores for Immunoassays Cangel Pui-yee Chan, Yvonne Bruemmel, Matthias Seydack, Analytical Chemistry	2004	79
Insulin Nanoparticles: A Novel Formulation Approach for Poorly Water Soluble Zn-Insulin Elaine Merisko‐Liversidge, Simon L. McGurk, Gary G. Liversidge Pharmaceutical Research NanoparticlesNovel Formulation ApproachEngineeringNanomaterialsNanotechnology	2004	70
Long-Acting Atypical Antipsychotics: Characterization of the Local Tissue Response Sara Montminy Paquette, Had Dawit, Magali B. Hickey, Pharmaceutical Research	2014	40
Developmental Pattern of Ventricular Atrial Natriuretic Peptide (ANP) Expression in Chronically Hypoxic Rats as an Indicator of the Hypertrophic Process James C. McKenzie, Kirk B. Kelley, Elaine Merisko‐Liversidge, Journal of Molecular and Cellular Cardiology Hypertrophic ProcessCardiomyopathyDevelopmental BiologyMolecular PhysiologyChronically Hypoxic Rats	1994	38
Direct Suppression of Phagocytosis by Amphipathic Polymeric Surfactants Nancy Watrous‐Peltier, Joanne Uhl, Vivian Steel, Pharmaceutical Research	1992	35
A Formulation Strategy for Gamma Secretase Inhibitor ELND006, a BCS Class II Compound: Development of a Nanosuspension Formulation with Improved Oral Bioavailability and Reduced Food Effects in Dogs Kevin P. Quinn, Rampurna Prasad Gullapalli, Elaine Merisko‐Liversidge, Journal of Pharmaceutical Sciences Improved Oral BioavailabilityFormulation StrategyMedicinePharmacotherapyNanosuspension Formulation	2011	25
Controlling the acute hemodynamic effects associated with IV administration of particulate drug dispersions in dogs Lawrence de Garavilla, Nancy Peltier, Elaine Merisko‐Liversidge Drug Development Research Pharmaceutical ScienceEngineeringDiagnostic AgentsPharmacotherapyBiomedical Engineering	1996	13
A Clathrin-Coated Vesicle-Mediated Pathway in Atrial Natriuretic Peptide (ANP) Secretion Robert M. Klein, Kirk B. Kelley, Elaine Merisko‐Liversidge Journal of Molecular and Cellular Cardiology Protein SecretionSignal TransductionMolecular PhysiologyBiochemistryMedicine	1993	10

Page 1